Protective effect of inhaled piretanide on the bronchial obstructive response to ultrasonically nebulized H2O. A dose-response study.
Inhaled furosemide prevents the obstructive response to several bronchoconstrictor stimuli in asthma. To verify whether this protective effect is also shared by other loop diuretics, we investigated the effect of inhaled piretanide on the bronchial obstructive response to ultrasonically nebulized distilled water (UNW) in ten patients with moderate, stable asthma. In a randomized, single-blind dose-response study, each subject performed an UNW test immediately after nebulization of different doses of piretanide between 12 and 48 mg or placebo. The effect of a single 40-mg dose of inhaled furosemide was also investigated in six subjects. Piretanide caused a significant, dose-dependent increase in UNW PD20 with respect to placebo, corresponding to 0.6 +/- 0.2 doubling doses (mean +/- SE) after 12 mg, 1.3 +/- 0.2 after 24 mg, and 2.0 +/- 0.2 after 48 mg, and had a remarkable diuretic effect; 40 mg of furosemide increased UNW PD20 by 2.3 +/- 0.3 doubling doses (p < 0.01), but showed only a modest diuretic activity. These data indicate that inhaled piretanide is as effective as furosemide in preventing UNW-induced asthma, and this effect is unrelated to their diuretic potency.
Bianco
S
S
Institute of Respiratory and Cardiovascular Diseases, Ospedale S. Raffaele, Milan, Italy.
Robuschi
M
M
Vaghi
A
A
Pieroni
M G
MG
Sestini
P
P
D000328:Adult; D000336:Aerosols; D001249:Asthma / Q000503:physiopathology; D001985:Bronchial Provocation Tests / Q000379:methods; D016084:Bronchoconstriction / Q000187:drug effects*; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005541:Forced Expiratory Volume / Q000187:drug effects; D005665:Furosemide / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D008297:Male; D009330:Nebulizers and Vaporizers; D010919:Placebos; D016037:Single-Blind Method; D013449:Sulfonamides / Q000008:administration & dosage / Q000494:pharmacology*; D014465:Ultrasonics; D014867:Water / Q000008:administration & dosage*
D000336:Aerosols; D004232:Diuretics; D010919:Placebos; D013449:Sulfonamides; D014867:Water; D005665:Furosemide; C015451:piretanide